SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BARALDI, Pier Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 41.329
AS - Asia 21.545
EU - Europa 20.108
SA - Sud America 3.358
AF - Africa 511
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 33
Totale 86.927
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 40.598
FI - Finlandia 8.286
SG - Singapore 7.549
CN - Cina 5.822
DE - Germania 3.424
BR - Brasile 2.595
UA - Ucraina 2.333
VN - Vietnam 2.164
HK - Hong Kong 1.848
TR - Turchia 1.834
GB - Regno Unito 1.364
IT - Italia 1.132
RU - Federazione Russa 908
SE - Svezia 872
FR - Francia 795
JP - Giappone 462
IN - India 461
MX - Messico 342
CA - Canada 292
AR - Argentina 273
PL - Polonia 258
BD - Bangladesh 249
ZA - Sudafrica 207
IQ - Iraq 175
NL - Olanda 144
ID - Indonesia 131
ES - Italia 113
PK - Pakistan 111
CO - Colombia 110
BE - Belgio 103
EC - Ecuador 94
MA - Marocco 89
TW - Taiwan 86
SA - Arabia Saudita 79
VE - Venezuela 76
CL - Cile 67
UZ - Uzbekistan 66
MY - Malesia 61
KR - Corea 57
LT - Lituania 57
PH - Filippine 53
PY - Paraguay 52
AE - Emirati Arabi Uniti 48
CZ - Repubblica Ceca 47
EG - Egitto 46
AT - Austria 37
IL - Israele 36
TN - Tunisia 36
KE - Kenya 33
AU - Australia 32
IR - Iran 30
PE - Perù 29
BO - Bolivia 27
JO - Giordania 27
UY - Uruguay 27
NP - Nepal 26
EU - Europa 24
IE - Irlanda 24
AZ - Azerbaigian 20
GR - Grecia 20
TH - Thailandia 20
CR - Costa Rica 19
CH - Svizzera 18
DZ - Algeria 18
ET - Etiopia 18
RO - Romania 18
KZ - Kazakistan 17
PS - Palestinian Territory 17
AL - Albania 16
HU - Ungheria 14
BH - Bahrain 13
KG - Kirghizistan 13
LB - Libano 13
OM - Oman 13
BG - Bulgaria 12
PA - Panama 12
PT - Portogallo 12
MD - Moldavia 11
SK - Slovacchia (Repubblica Slovacca) 11
SY - Repubblica araba siriana 11
HR - Croazia 10
LV - Lettonia 10
NO - Norvegia 10
NZ - Nuova Zelanda 10
AO - Angola 9
DO - Repubblica Dominicana 9
JM - Giamaica 9
RS - Serbia 9
SN - Senegal 9
TT - Trinidad e Tobago 9
HN - Honduras 8
MN - Mongolia 8
NI - Nicaragua 8
BY - Bielorussia 7
CI - Costa d'Avorio 7
MT - Malta 6
MU - Mauritius 6
SV - El Salvador 6
XK - ???statistics.table.value.countryCode.XK??? 6
BA - Bosnia-Erzegovina 5
Totale 86.818
Salva come PNG Salva come JPEG
Città #
Helsinki 7.702
Singapore 4.930
Ashburn 3.992
Woodbridge 3.789
Fairfield 3.579
Dallas 2.751
Houston 2.479
Jacksonville 2.449
Chandler 2.073
San Jose 2.012
Ann Arbor 1.911
Hong Kong 1.725
Santa Clara 1.575
Beijing 1.534
Seattle 1.527
Wilmington 1.378
Cambridge 1.093
Izmir 805
Nanjing 776
Ho Chi Minh City 694
Los Angeles 512
Princeton 511
Hanoi 493
Tokyo 422
Boardman 404
New York 403
Lauterbourg 396
Munich 367
San Diego 322
Ferrara 270
Shenyang 263
São Paulo 249
Milan 234
Shanghai 226
Hefei 220
Nanchang 213
Warsaw 209
Mexico City 197
Tianjin 182
London 178
Hebei 157
Falkenstein 154
San Mateo 153
Orem 151
Changsha 149
Bremen 144
Addison 141
Chicago 134
Jiaxing 121
Frankfurt am Main 115
Dearborn 114
Dong Ket 114
Brooklyn 112
Turku 112
Jinan 111
Council Bluffs 109
The Dalles 109
Montreal 100
Chennai 99
Brussels 98
Da Nang 95
Philadelphia 92
Johannesburg 90
Amsterdam 88
Haiphong 88
Falls Church 86
Moscow 86
Baghdad 84
Norwalk 84
Rio de Janeiro 84
Atlanta 80
Kunming 79
Redwood City 78
Zhengzhou 76
San Francisco 74
Guangzhou 72
Buffalo 68
Denver 68
Stockholm 66
Toronto 66
Phoenix 65
Boston 60
Taipei 60
Mountain View 59
Poplar 58
Tashkent 58
Manchester 57
Belo Horizonte 54
Brasília 54
Mumbai 53
Ningbo 51
Jakarta 48
Auburn Hills 47
Orange 47
Hải Dương 46
Des Moines 44
Verona 44
Dhaka 43
Ankara 42
Quito 41
Totale 60.177
Salva come PNG Salva come JPEG
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 3.087
1,4-Diketones via Isoxazole Intermediates 3.065
1,2,3-triazolo[5,4-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: A new class of A(2A) adenosine receptor antagonists 3.032
Nuovo impiego di poliammidi eterocicliche e benzoeterocicliche strutturalmente correlate all'antibiotico naturale Distamicina A 1.961
[2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid inhibits DNA binding to transcription factor Sp1 523
The use of phase-transfer catalysis for the N-alkylation of indole. 511
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 327
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 308
A glance at adenosine receptors: Novel target for antitumor therapy 303
A new, efficient synthesis of muscimol (5-ammoniomethylisoxazol-3-olate). 289
Design, synthesis and biological evaluation of 3-substituted-2-oxindole hybrid derivatives as novel anticancer agents 288
1-methyl-3-nitro-5-methoxycarbonyl pyrazole 287
A facile, efficient synthesis of 2-substituted-4-hydroxy-2-cyclopenten-1-ones 286
A3 adenosine receptor antagonists: History and future perspectives 282
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 279
A [3+2] nitrile oxide intermolecular cycloaddition approach to 4,5-dihydro-3(2H)-furanone and 3(2H)-furanone ring systems: application to the formal synthesis of (±)-ascofuranone and geiparvarin. 277
The A3 adenosine receptor: history and perspectives 275
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 272
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 270
Azaprostaglandin Analogues. Synthesis and Biological Properties of 11-Azaprostaglandin Derivatives 265
3,5-Disubstituted isoxazoles as a latent aldol moiety: Application to the synthesis of (±)-[6]-gingerol 264
A formal total synthesis (±)-forskolin through [3+2] nitrile oxide cycloaddition chemistry 264
A synthetic approach for the preparation of rigid analogs of 1,3-dipropyl-7-methyl-8-aryl/heteroarylstyryl xanthines 263
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3’,4’,5’-Trimethoxyphenyl)-2-Aryl-1H-Imidazole 261
A convenient synthesis of unsymmetrically substituted terphenyls of biologically active stilbenes via a double Suzuki cross-coupling protocol 261
Synthesis and biological evaluation of 2-and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization 259
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation 256
Adenosine receptors and human melanoma 252
A [3 + 2] nitrile oxide cycloaddition approach to retinoids 251
2,3a,5,6,7,7a-Hexahydro-3H,4H-benzothiophene-3,4-dione and cyclopenta[b]tetrahydrothiophene-3,4-dione enolate anions as synthetic equivalents to cyclohex-2-enone and cyclopent-2-enone C-2-carbanions. 251
Allosteric modulators for the A1-adenosine receptor 249
Design, synthesis, in vitro, and in vivo anticancer and antiangiogenic activity of novel 3-arylaminobenzofuran derivatives targeting the colchicine site on tubulin 247
Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders 246
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 245
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 243
A new nitrile oxide based synthesis of the antitumor agent geiparvarin 239
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 237
DNA minor groove binders as potential antitumor and antimicrobial agents 236
Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents 236
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 236
3,5-Disubstituted Isoxazoles as Synthons for (±)-Pyrenophorin and (±)-Vermiculine Synthesis 234
Allosteric enhancers for A(1) adenosine receptor 234
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 234
History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents 234
Design, synthesis and in vitro cytotoxicity of a cis-dichloroplatinum(II) complex linked to the minor groove binder stallimycin 232
Design, synthesis and antiproliferative activity of novel heterobivalent hybrids based on imidazo[2,1-b][1,3,4]thiadiazole and imidazo[2,1-b][1,3]thiazole scaffolds 232
2-Arylamino-4-amino-5-aroylthiazoles. "One-pot" synthesis and biological evaluation of a new class of inhibitors of tubulin polymerization 230
Blockade of A2A receptors plus L-DOPA after nigrostriatal lesion results in GAD67 mRNA changes different from L-DOPA alone in the rat globus pallidus and substantia nigra reticulata 229
Pyrazolo [4,3-e][1,2,4]triazolo[1,5-c]pyrimidine template: Organic and medicinal chemistry approach 228
null 227
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 227
A new direct glycosylation of pyrimidine, pyrazole, imidazole and purine heterocycles via their N-tetrahydropyranyl (THP) derivatives 227
Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA 225
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility 225
Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor 225
Active γ-manganese dioxide promoted conversion of 4,5-dihydro-1,2-oxazoles to 1,2-oxazoles. 225
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH) 223
1H-pyrazolo[2,3-d][1,2,4]triazine-3,7-diones as a new class of human leukocyte elastase inhibitors 222
Novel 8-heterocyclyl xanthine derivatives in drug development - An update 222
Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylation 222
Hybrid molecules between distamycin A and active moieties of antitumor agents 221
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 220
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 219
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 219
Carboxyl activation in peptide synthesis using 4-oximino-pyrazol-5-ones 218
Hybrid molecules based on distamycin A as potential antitumor agents 218
Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocycles 217
5-heteroarylcarbamoylamino-pyrazolo-triazolo pyrimidines as hA3 adenosine receptor antagonists. 217
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 216
Geiparvarin analogs. 2. Synthesis and cytostatic activity of 5-(4-arylbutadienyl)-3(2H)-furanones and of N-substituted 3-(4-oxo-2-furanyl)-2-buten-2-yl carbamates. 215
Current status of A1 adenosine receptor allosteric enhancers 215
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2 214
A one-pot glycosylation of tetrahydropyranyl (THP) ether intermediates 213
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 212
Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1,4] benzodiazepine and minor-groove-binding oligopyrrole carriers 212
Ethyl 2,4-dioxoalkanoates as starting materials for a convenient route to 3(2H)-furanones and 3(2H)-furanimines 211
A new simple synthesis of a-substituted acrylonitriles 211
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 211
Methyl 4-oxothiolane-3-carboxylate and methyl 2-methyl-4-oxothiolane-3- carboxylate anions as synthetic equivalents of α-acrylate and α-crotonate anions. Formal synthesis of integerrinecic acid 210
Synthesis of hybrid distamycin-cysteine labeled with 99mTc: a model for a novel class of cancer imaging agents 210
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 209
Synthesis and biological evaluation of 2-(3 ',4 ',5 '-trimethoxybenzoyl)-3-amino 5-aryl thiophenes as a new class of tubulin inhibitors 208
7-substituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: importance of modifications at the side chain on the activity and solubility. 208
Cinnamoyl nitrogen mustard derivatives of pyrazole analogues of tallimustine modified at the amidino moiety: design, synthesis, molecular modeling and antitumor activity studies 207
Structure-activity relationship studies of a new series of imidazo[2,1-f] purinones as potent and selective A3 adenosine receptor antagonists 207
Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor 207
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 207
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 206
Structure-activity relationships around the KN-62, a potent antagonist of the P2X(7)receptor 206
Discovery and Optimization of a Series of 2-Aryl-4-Amino-5-(3 ',4 ',5 '-trimethoxybenzoyl)Thiazoles as Novel Anticancer Agents 206
A new synthetic approach to indazole synthesis 206
7-substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A(2A) adenosine receptor antagonists: A study on the importance of modifications at the side chain on the activity and solubility 206
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and linked Heterocycles as template for the adenosine receptor antagonism: Medicinal chemistry approach and sar considerations 205
A mild one-pot synthesis of thieno[3,4-c]pyrazoles and their conversion into pyrazole analogs of o-quinodimethane 204
[3H]MRE2029F20 a new selective antagonist radioligand for the human A2B adenosine receptors. 204
A new synthetic approach to pyrazolo[3,4-c]-1,2,5-oxadiazoles 204
Design, synthesis and growth inhibition activity of bis-epoxyethyl derivatives of stallimycin modified on the amidino moiety 203
Synthesis of a new series of pyrazolo[1,5-a]pyrimidines structurally related to zaleplon 202
Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor 201
Preparation of 3,4-dihydroxy-1-benzeneethanol: a reinvestigation 200
Totale 34.145
Salva come PNG Salva come JPEG
Categoria #
all - tutte 324.366
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.207
Totale 327.573
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.172 0 0 0 0 0 0 0 0 0 784 835 553
2021/20225.094 159 470 372 291 373 250 208 243 197 361 528 1.642
2022/20234.800 508 249 108 646 881 773 145 390 611 31 286 172
2023/20242.411 243 307 129 82 170 287 95 394 28 60 56 560
2024/20259.331 291 294 752 335 1.154 770 273 638 1.285 1.084 1.377 1.078
2025/202634.790 2.653 1.709 4.045 3.576 3.659 1.892 3.275 1.339 9.919 2.723 0 0
Totale 87.406